217 related articles for article (PubMed ID: 26451311)
61. Common tcr-Beta chain rearrangements in short-term cultured lymphocytes infiltrating ovarian-tumors.
Mayer R; Han A; Fisk B; Ioannides C
Int J Oncol; 1993 May; 2(5):851-6. PubMed ID: 21573638
[TBL] [Abstract][Full Text] [Related]
62. Association of Germline Variants in Natural Killer Cells With Tumor Immune Microenvironment Subtypes, Tumor-Infiltrating Lymphocytes, Immunotherapy Response, Clinical Outcomes, and Cancer Risk.
Xu X; Li J; Zou J; Feng X; Zhang C; Zheng R; Duanmu W; Saha-Mandal A; Ming Z; Wang E
JAMA Netw Open; 2019 Sep; 2(9):e199292. PubMed ID: 31483464
[TBL] [Abstract][Full Text] [Related]
63. The repertoire of CD4+ CD28- T cells in rheumatoid arthritis.
Schmidt D; Martens PB; Weyand CM; Goronzy JJ
Mol Med; 1996 Sep; 2(5):608-18. PubMed ID: 8898376
[TBL] [Abstract][Full Text] [Related]
64. Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascites.
He Z; Wang S; Qiao G; Wang X; Zhou X; Zhu S; Yuan Y; Morse MA; Hobeika A; Ren J; Lyerly HK
Am J Transl Res; 2020; 12(7):3940-3952. PubMed ID: 32774747
[TBL] [Abstract][Full Text] [Related]
65. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
66. [Detection of lymphocyte subsets in the peripheral blood of patients with malignant ovarian tumors].
Liu M; Xie J; Zhao S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Jun; 30(6):627-9, 634. PubMed ID: 24909286
[TBL] [Abstract][Full Text] [Related]
67. T cell receptor next-generation sequencing reveals cancer-associated repertoire metrics and reconstitution after chemotherapy in patients with hematological and solid tumors.
Simnica D; Akyüz N; Schliffke S; Mohme M; V Wenserski L; Mährle T; Fanchi LF; Lamszus K; Binder M
Oncoimmunology; 2019; 8(11):e1644110. PubMed ID: 31646093
[TBL] [Abstract][Full Text] [Related]
68. Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication.
Burugu S; Asleh-Aburaya K; Nielsen TO
Breast Cancer; 2017 Jan; 24(1):3-15. PubMed ID: 27138387
[TBL] [Abstract][Full Text] [Related]
69. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
70. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution.
Packer AN; Muraro PA
Exp Hematol; 2007 Mar; 35(3):516-21. PubMed ID: 17309832
[TBL] [Abstract][Full Text] [Related]
71. Differences in the recognition of tumor-specific CD8+ T cells derived from solid tumor, metastatic lymph nodes and ascites in patients with gastric cancer.
Kono K; Ichihara F; Iizuka H; Sekikawa T; Matsumoto Y
Int J Cancer; 1997 Jun; 71(6):978-81. PubMed ID: 9185700
[TBL] [Abstract][Full Text] [Related]
72. Preferential usage of T-cell receptor alpha beta variable regions among tumor-infiltrating lymphocytes in primary human malignant melanomas.
Thor Straten P; Schøller J; Hou-Jensen K; Zeuthen J
Int J Cancer; 1994 Jan; 56(1):78-86. PubMed ID: 8262682
[TBL] [Abstract][Full Text] [Related]
73. Characterization of effusion-infiltrating T cells: benign versus malignant effusions.
Atanackovic D; Block A; de Weerth A; Faltz C; Hossfeld DK; Hegewisch-Becker S
Clin Cancer Res; 2004 Apr; 10(8):2600-8. PubMed ID: 15102661
[TBL] [Abstract][Full Text] [Related]
74. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
75. Longitudinal analysis of peripheral blood T cell receptor diversity in patients with systemic lupus erythematosus by next-generation sequencing.
Thapa DR; Tonikian R; Sun C; Liu M; Dearth A; Petri M; Pepin F; Emerson RO; Ranger A
Arthritis Res Ther; 2015 May; 17(1):132. PubMed ID: 26001779
[TBL] [Abstract][Full Text] [Related]
76. Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment.
Shi G; Shi P; Yu Y; Xu J; Ma J; Zhang Y; Dong Z; Shen L; Dai L; Cheng L; Cheng P; Deng H
Mol Ther Oncolytics; 2021 Dec; 23():488-500. PubMed ID: 34901391
[TBL] [Abstract][Full Text] [Related]
77. High-throughput T cell receptor sequencing reveals distinct repertoires between tumor and adjacent non-tumor tissues in HBV-associated HCC.
Chen Y; Xu Y; Zhao M; Liu Y; Gong M; Xie C; Wu H; Wang Z
Oncoimmunology; 2016; 5(10):e1219010. PubMed ID: 27853640
[TBL] [Abstract][Full Text] [Related]
78. Heterogeneity of T-cell clones infiltrating primary malignant melanomas.
Yazdi AS; Morstedt K; Puchta U; Ghoreschi K; Flaig MJ; Rocken M; Sander CA
J Invest Dermatol; 2006 Feb; 126(2):393-8. PubMed ID: 16374454
[TBL] [Abstract][Full Text] [Related]
79. Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.
Tahara H; Fujio K; Araki Y; Setoguchi K; Misaki Y; Kitamura T; Yamamoto K
J Immunol; 2003 Aug; 171(4):2154-60. PubMed ID: 12902522
[TBL] [Abstract][Full Text] [Related]
80.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
